No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PBLA Panbela Therapeutics
- 0.420
- -0.070-14.20%
15min DelayClose Apr 19 16:00 ET
2.04MMarket Cap-1P/E (TTM)
0.490High0.400Low263.02KVolume0.459Open0.490Pre Close116.42KTurnover5.42%Turnover RatioLossP/E (Static)4.85MShares477.00052wk High-0.43P/B2.04MFloat Cap0.40052wk Low--Dividend TTM4.85MShs Float211200.000Historical High--Div YieldTTM18.28%Amplitude0.400Historical Low0.442Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Panbela Applies to List on CBOE
By Stephen Nakrosis Panbela Therapeutics, whose shares were recently delisted from the Nasdaq, said Thursday it will seek to list on the US Equity Listings Tier II Chicago Board of Options Exchange.
Panbela Therapeutics, Recently Delisted From Nasdaq and Now on OTCQB, to Seek CBOE Stock Listing
Panbela Therapeutics, Recently Delisted From Nasdaq and Now on OTCQB, to Seek CBOE Stock Listing
Panbela Therapeutics Files for Stock and Warrant Offering
Panbela Therapeutics Files for Stock and Warrant Offering
Express News | Panbela Announces Poster Presentation at American Association for Cancer Research:
Panbela Therapeutics Shifts From Nasdaq to OTCQB Market
Panbela Announces Transfer to OTCQB Market
Panbela Therapeutics, Inc. (OTCQB: PBLA), today announced that its common stock has been approved for quotation on the OTCQB market. Panbela's common stock will be eligible for quotation on the OTCQB starting on April 17, 2024, under the symbol "PBLA."
Comments
$Panbela Therapeutics(PBLA.US$ I will vote against RS. This is crazy, take a look at most RS, all in a dump. Just not long already did a RS. This is suicide. wake up, I would rather die gloriously without RS than let others take advantage of all small retail investors. That's my strong & obvious opinion..
5
$Panbela Therapeutics(PBLA.US$ Forgotten stock for now
1
Percentage of shares sold short:
$Aclarion(ACON.US$ 0.76%
$SenesTech(SNES.US$ 7.6%
$Transcode Therapeutics(RNAZ.US$ 71.11%
$Revelation Biosciences(REVB.US$ 9.24%
$Panbela Therapeutics(PBLA.US$ 2.21%
$Aclarion(ACON.US$ 0.76%
$SenesTech(SNES.US$ 7.6%
$Transcode Therapeutics(RNAZ.US$ 71.11%
$Revelation Biosciences(REVB.US$ 9.24%
$Panbela Therapeutics(PBLA.US$ 2.21%
1
2
🚀 PREPARING FOR LIFTOFF
$Panbela Therapeutics (PBLA.US)$ is in a fight for its life, and compliancy. RSI indicates that this is undervalued. Time to buy my friends!
FILL THOSE GAPS
FILL THOSE GAPS
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg